Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- Status
- RECRUITING
- Phase
- PHASE2
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- NA
Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3